Yahoo Movies'Zack Snyder's Justice League': Creating Steppenwolf the Space Knight
VFX video progression of Steppenwolf in Zack Snyder's Justice League.
VFX video progression of Steppenwolf in Zack Snyder's Justice League.
The "Electric Vehicle (EV) Battery Housing Market - A Global and Regional Analysis: Focus on Battery Housing Materials, Component, Cell Format, and Application, Supply Chain Analysis, Country Analysis, and Impact of COVID-19 - Analysis and Forecast, 2019-2025" report has been added to ResearchAndMarkets.com's offering.
New York, New York--(Newsfile Corp. - April 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") between November 8, 2019 and April 6, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Middle District of North Carolina. To get ...
The "Robotic Surgery Devices Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
Lewisville, Texas--(Newsfile Corp. - April 21, 2021) - Today, Parsec Capital Acquisitions Corp. ("Company" or "Parsec"), filed a confidential S1 as a Special Purpose Acquisition Company (SPAC) with a focus on the space economy, technology and transport industries. Astro Aerospace (OTCQB: ASDN) ("Astro") has sponsored their SPAC. Astro, a global leader in electric vertical take-off and landing (eVTOL) aerial vehicles and drones, is a pioneer in the aerial eVTOL market, which has an ...
Leona Derbyshire, Matej Bulander and Allyx Queen were last seen in Chorley at around 8.30pm on Tuesday night.
Your purchase of the pocket-sized Nimble Eco-Friendly CHAMP 10k PD Portable Charger helps keep 400 million tons of plastic out of landfills each year.
Pakistan held on to win the first Twenty20 against Zimbabwe on Wednesday by managing to defend a modest total of 149-7. Zimbabwe only got 138-7 in reply after Usman Qadir's 3-29 thwarted the home team at Harare Sports Club and gave Pakistan an 11-run victory. Opener Mohammad Rizwan batted through the Pakistan innings for his 82 not out from 61 balls.
NEW DELHI — Twenty-two COVID-19 patients on ventilators died in a hospital in western India on Wednesday when their oxygen supply was interrupted by a leak in a supply line, officials said. Suraj Mandhar, the district collector, said the supply of oxygen has since resumed to other patients. Fire officer Sanjay Bairagi said the leak was halted by the fire service within 15 minutes, but there was supply disruption in the Zakir Hussain Hospital in Nashik, a city in Maharashtra state that is the worst hit by the latest surge in coronavirus cases in the country. Television images showed white fumes spreading in the hospital area, causing panic. Surinder Sonone, a police officer, said the leak occurred in a pipe connecting the oxygen supply to the main tank in the hospital complex. Five of the 140 COVID-19 patients were shifted to another hospital, he said. The state government ordered an investigation of the leak, state Health Minister Rajesh Tope said. India has reported a new record 295,041 coronavirus cases, as the daily death toll crossed 2,000 for the first time. Even with hospitals struggling, Prime Minister Narendra Modi on Tuesday advised state governments against imposing a harsh lockdown in favour of micro-containment zones as he sought to avoid another economic slump. The surge in India has exacerbated the slowdown in global vaccination campaigns. India is a major vaccine producer but was forced it to delay deliveries of shots to focus on its domestic demand. So far, India has administered over 130 million doses of vaccines in a nation of nearly 1.4 billion since mid-January. Overall, India has reported more than 15.6 million confirmed cases, the second highest behind the United States. The number of deaths stood at 182,553. The Associated Press
Air traffic will recover more slowly than previously expected from the COVID-19 pandemic, as vaccination delays and government "risk aversion" slows the reopening of routes, global airlines body IATA said on Wednesday. Global traffic this year will amount to 43% of pre-crisis levels based on passenger numbers and distance flown, the International Air Transport Association said, below the 51% it had forecast late last year. "This crisis is longer and deeper than anyone could have expected," Director General Willie Walsh said.
The former cage fighter admitted contempt of court after he falsely claimed not to know a man it was said had witnessed the crash.
Cheryl Burke is hoping to make amends with Ian Ziering — her former partner on "Dancing with the Stars."
Did you know the carbon footprint of a cell phone is 154 pounds? The power to reduce that number is in your hands.
Northwest Syria received its first batch of coronavirus vaccinations through the global vaccine-sharing platform COVAX on Wednesday with inoculations set to start May 1. A total of 54,000 doses of the AstraZeneca vaccine arrived in Syria's Idlib, the first for opposition-held Syrian territory, through the Bab al Hawa border crossing with Turkey. Two more batches are expected to arrive throughout the year to cover around 850,000 people in northwest Syria, said Hossam Kora, who heads coordination for coronavirus within the Idlib health directorate.
Abstract: - Global Tissue Engineering Market to Reach $26. 8 Billion by 2027. - Amid the COVID-19 crisis, the global market for Tissue Engineering estimated at US$11 Billion in the year 2020, is projected to reach a revised size of US$26.New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Engineering Industry" - https://www.reportlinker.com/p06033135/?utm_source=GNW 8 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record a 12.1% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiology & Vascular segment is readjusted to a revised 15.7% CAGR for the next 7-year period. - The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 13.1% CAGR - The Tissue Engineering market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR. - Cord Blood & Cell Banking Segment to Record 14.7% CAGR - In the global Cord Blood & Cell Banking segment, USA, Canada, Japan, China and Europe will drive the 14.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.2 Billion by the year 2027. - Select Competitors (Total 33 Featured) - Acelity L.P. Inc.Advanced Cell TechnologyAllergan PlcArteriocyteAthersysBaxter International IncBioMimetic TherapeuticsCook Biotech Inc.CryoLifeDePuy Synthes (Johnson & Johnson Services, Inc.)Integra Life Sciences CorporationLifeCell Kinetic ConceptsMedtronicOrganogenesis Inc.RTI surgicalSanofiStemCells, Inc.Stryker CorporationZimmer Biomet Read the full report: https://www.reportlinker.com/p06033135/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 2: World 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 Table 3: World Current & Future Analysis for Orthopedics, Musculoskeletal & Spine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 4: World 7-Year Perspective for Orthopedics, Musculoskeletal & Spine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 5: World Current & Future Analysis for Cardiology & Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 6: World 7-Year Perspective for Cardiology & Vascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 7: World Current & Future Analysis for Cord Blood & Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 8: World 7-Year Perspective for Cord Blood & Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 9: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 10: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 11: World Current & Future Analysis for Gastrointestinal & Gynecology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 12: World 7-Year Perspective for Gastrointestinal & Gynecology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 Table 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 15: USA Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 16: USA 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 CANADA Table 17: Canada Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 18: Canada 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 JAPAN Table 19: Japan Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 20: Japan 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 CHINA Table 21: China Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 22: China 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 EUROPE Table 23: Europe Current & Future Analysis for Tissue Engineering by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR Table 24: Europe 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 Table 25: Europe Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 26: Europe 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 FRANCE Table 27: France Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 28: France 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 GERMANY Table 29: Germany Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 30: Germany 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 ITALY Table 31: Italy Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 32: Italy 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 UNITED KINGDOM Table 33: UK Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 34: UK 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 REST OF EUROPE Table 35: Rest of Europe Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 36: Rest of Europe 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 ASIA-PACIFIC Table 37: Asia-Pacific Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 38: Asia-Pacific 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 REST OF WORLD Table 39: Rest of World Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR Table 40: Rest of World 7-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2020 & 2027 IV. COMPETITION Total Companies Profiled: 33Read the full report: https://www.reportlinker.com/p06033135/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
The ITV weather presenter's children had told their mother 'he's going to kill you'.
Jane Fonda said the "stars began to whirl and the pier began to shake" when she had her first kiss ever with actor James Franciscus
Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today confirmed the emission of smoke at 16:29 JST from the power panel of a Rail Guided Vehicle (RGV) located on the basement of the N3 Building (300mm line) of Naka Factory. The smoke was extinguished immediately by Renesas employees after it began. Following the confirmation of the site by the fire department and maintenance of the power panel, which was the cause of the smoke, production has been resumed as of 20:00 JST on the first floor and the second floor of the N3 Building. There are no impacts to the production and shipment outlook announced in "UPDATE 6 - Notice Regarding the Semiconductor Manufacturing Factory (Naka Factory) Fire". We also confirmed no casualties from this incident.
Climate change is influencing reproductive choices.
The Swedish government warned of new and tougher steps if people chose to ignore existing COVID-19 restrictions and further raised pressure on healthcare services already struggling to cope with a third wave of the disease. Sweden, whose still mostly voluntary measures has made it an outlier in its response to the pandemic, has seen the number of people in intensive care rise to its highest level since the initial outbreak a year ago. In some regions, intensive care has been filled to maximum capacity and the number of available beds for those worst ill is below 20% across the nation.
Increase in adoption of digitalization and rise in physical & virtual threats in the BFSI sector fuel the global BFSI security market growth. By end-user, the banks segment held the highest market share in 2019. Moreover, the market across North America region held the highest market share in 2019, with highest market share, and is expected to continue its dominant share in terms of revenue throughout the forecast period.Portland.OR, April 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global BFSI security market garnered $42.73 billion in 2019, and is estimated to generate $114.498 billion by 2027, manifesting a CAGR of 13.2% from 2020 to 2027. The report provides an extensive analysis of changing market dynamics, key segments, value chain, top investment pockets, regional landscape, and competitive scenario. Increase in adoption of digitalization and rise in physical & virtual threats in the BFSI sector fuel the global BFSI security market growth. However, risk of third-party services and huge cost for implementation of technological securities in the BFSI sector restrain the market growth. On the other hand, surge in adoption of internet in the BFSI sector create new opportunities in the next few years. Get Instant Access – Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/10926 Covid-19 Scenario: BFSI Securityhas gained momentum during covid-19, as the BFSI security providers are offering software-as-a-services under security platforms.The industry has witnessed a steep increase in the use and adoption of online and digitalized financial services globally. This, in turn, has become one of the major growth factors for the BFSI security market during this global health crisis. The report provides detailed segmentation of the global BFSI security market based on security type, enterprise size, end user, and region. By security type, the information security segment accounted for the largest share in 2019, contributing to nearly three-fifths of the total market share, and is expected to maintain its lead position throughout the forecast period. Moreover, this segment is expected to witness the fastest CAGR of 13.7% from 2020 to 2027. The report also discusses physical security segment. Enquire For More: https://www.alliedmarketresearch.com/purchase-enquiry/10926 By end-user, the banks segment held the highest market share in 2019, accounting for more than three-fifths of the global BFSI security market, and is estimated to maintain its leadership status during the forecast period. However, insurance companies segment is projected to portray the highest CAGR of 14.5% from 2020 to 2027. By region, North America held the highest market share in 2019, contributing to more than one-third of the total share, and is expected to continue its dominant share in terms of revenue throughout the forecast period. On the other hand, the Asia-Pacific region would register the largest CAGR of 15.3% from 2020 to 2027. The report also analyzes regions including Europe and LAMEA. Get detailed COVID-19 impact analysis on the BFSI Security Market: https://www.alliedmarketresearch.com/request-for-customization/10926?reqfor=covid Leading players of the global BFSI security market analyzed in the research include IBM Corporation, McAfee, LLC, Microsoft, Booz Allen Hamilton Inc., Broadcom, Cisco Systems, Inc., Dell Inc., Honeywell International Inc., Sophos Ltd, and Trend Micro Incorporated. Access Avenue (Premium on-demand, subscription-based pricing model) @ https://www.alliedmarketresearch.com/Avenue-Membership-details Avenue, a user-based library of global market report database, provides comprehensive reports pertaining to the world's largest emerging markets. It further offers e-access to all the available industry reports just in a jiffy. By offering core business insights on the varied industries, economies, and end users worldwide, Avenue ensures that the registered members get an easy as well as single gateway to their all-inclusive requirements. About Us: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com